| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/11/2005 | US6841355 Positioning solid support into injury; wound healing agents; peptide |
| 01/11/2005 | US6841171 Obtained by subjecting oyster flesh to the action of a protease under suitable conditions exhibit a free-radical scavenging activity which is even higher than that observed for the aqueous oyster extracts |
| 01/11/2005 | US6841162 Cosmetic or dermatological composition contacting at least one natural or recombinant spider silk or an analog |
| 01/11/2005 | US6841158 Chicken embryo lethal orphan or fowl adenovirus type 1 genome contains a deletion consisting essentially of nucleotides 41,731-43,684 of the wild type |
| 01/11/2005 | US6841156 Treating cholinergic controlled secretions including excessive sweating, lacrimation and mucus secretion; relieving pain associated with smooth muscle disorders, including spasms in the sphincter muscles; type A & B toxins |
| 01/11/2005 | US6841155 Immunization against and treatment for infection by H. pylori |
| 01/11/2005 | US6841152 Methods for protecting against autoimmune diabetes |
| 01/11/2005 | US6841147 Stem cell factor compositions |
| 01/11/2005 | CA2342072C Kunitz domain polypeptide zkun6 |
| 01/11/2005 | CA2269783C Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules |
| 01/11/2005 | CA2267670C Method for preparing human stem cell factor polypeptide |
| 01/11/2005 | CA2169631C A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 01/11/2005 | CA2128711C Trypsin inhibitors |
| 01/11/2005 | CA2088343C Stable fibrinogen solution |
| 01/11/2005 | CA2069870E Treatment of atopic disorders with gamma-interferon |
| 01/11/2005 | CA2033175C Self-assembled, defective, non-self-propagating viral particles |
| 01/06/2005 | WO2005001096A1 Vaccines against sars |
| 01/06/2005 | WO2005001092A2 Compositions and methods for diagnosing and treating cancers |
| 01/06/2005 | WO2005001075A1 Rdp58 compositions and methods for modulating the activity of osteoclasts and osteoblasts |
| 01/06/2005 | WO2005001033A2 Tolerance induction and maintenance in hematopoietic stem cell allografts |
| 01/06/2005 | WO2005000895A2 Vegf traps and therapeutic uses thereof |
| 01/06/2005 | WO2005000893A2 Pharmaceutical composition comprising cyclic somatostin analogues |
| 01/06/2005 | WO2005000892A2 Glp-1 analog fusion plroteins |
| 01/06/2005 | WO2005000891A2 Thrombopoietin proteins with improved properties |
| 01/06/2005 | WO2005000887A1 Rasgap derived peptide for selectively killing cancer cells |
| 01/06/2005 | WO2005000886A2 T24 antigen for immunodiagnosis of taenia solium cysticercosis |
| 01/06/2005 | WO2005000884A1 Poly-gamma-glutamic conjugates for eliciting immune responses directed against bacilli |
| 01/06/2005 | WO2005000882A2 Dna fragments and proteins encoded by said dna isolated from bifidobacteria |
| 01/06/2005 | WO2005000879A1 Cyclosporin derivatives for the treatment of immune disorders |
| 01/06/2005 | WO2005000878A2 Compositions of lipopeptide antibiotic derivatives and methods of use thereof |
| 01/06/2005 | WO2005000877A2 Novel melanocortin receptor templates, peptides, and use thereof |
| 01/06/2005 | WO2005000875A2 Compositions and methods comprising a ligand of chemerin receptor |
| 01/06/2005 | WO2005000874A1 Biologically active peptide comprising tyrosyl-seryl-valine (ysv) |
| 01/06/2005 | WO2005000872A2 Collagen mimics |
| 01/06/2005 | WO2005000871A2 Peptides antagonistic to an anti-angiogenic antibody and uses therefor |
| 01/06/2005 | WO2005000403A2 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
| 01/06/2005 | WO2005000355A1 Treatment of tumor by cotransferring chemotherapeutic agent with cytokine gene |
| 01/06/2005 | WO2005000351A2 Combination therapy for b cell disorders |
| 01/06/2005 | WO2005000343A1 Use of a clostridial toxin to reduce appetite |
| 01/06/2005 | WO2005000341A1 Use of cytosolic phospholipid hydroperoxide glutathione peroxidase to reduce tumor growth |
| 01/06/2005 | WO2005000340A1 Synergistic compositions comprising erythropoietin and succinic acid (salt) |
| 01/06/2005 | WO2005000339A2 Melanocortin receptor 4(mc4) agonists and their uses |
| 01/06/2005 | WO2005000338A1 Uses of melanocortin-3 receptor (mc3r) agonist peptides |
| 01/06/2005 | WO2005000337A1 Compositions and methods for treatment of rosacea |
| 01/06/2005 | WO2005000336A2 The use of caldag-gefi inhibitors as antithrombotic agents |
| 01/06/2005 | WO2005000335A2 Use of genes differentially expressed during aging of liver for treatment and diagnosis |
| 01/06/2005 | WO2005000334A1 Abuse resistant amphetamine compounds |
| 01/06/2005 | WO2005000333A1 Methods to mobilize progenitor/stem cells |
| 01/06/2005 | WO2005000332A2 Therapeutic agent for soft tissue sarcoma |
| 01/06/2005 | WO2005000316A1 External preparation for improving coital function |
| 01/06/2005 | WO2005000283A2 A method of treating degenerative disc disease |
| 01/06/2005 | WO2005000270A2 Inhalable formulations for treating pulmonary hypertension and methods of using same |
| 01/06/2005 | WO2005000246A2 Methods and compositions for treating rheumatoid arthritis |
| 01/06/2005 | WO2005000244A2 Methods and compositions for treating rheumatoid arthritis |
| 01/06/2005 | WO2005000239A2 Lyase treatment for p. carinii |
| 01/06/2005 | WO2005000236A2 Transdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome |
| 01/06/2005 | WO2005000230A2 Methods of treating hyperproliferative cell disorders |
| 01/06/2005 | WO2005000229A2 Compositions and methods for modulating s-nitrosoglutathione reductase |
| 01/06/2005 | WO2005000227A2 Methods of treating tnf-mediated disorders |
| 01/06/2005 | WO2005000222A2 Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins |
| 01/06/2005 | WO2005000215A2 Methods for treating pain |
| 01/06/2005 | WO2005000201A2 Modulation of apolipoprotein (a) expression |
| 01/06/2005 | WO2005000198A2 An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same |
| 01/06/2005 | WO2005000195A2 A pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger |
| 01/06/2005 | WO2005000192A2 Glycogen synthase kinase-3 inhibitors |
| 01/06/2005 | WO2004103348A3 Solid particles comprising an anticonvulsant or an immunosuppressive coated with one or more surface modifiers |
| 01/06/2005 | WO2004101494B1 Calpain inhibitors |
| 01/06/2005 | WO2004096845A3 Beta-amyloid inhibitors and use thereof |
| 01/06/2005 | WO2004096257A3 Genetic modification of targeted regions of the cardiac conduction system |
| 01/06/2005 | WO2004092213B1 Gene expressed in prostate cancer, methods and use thereof |
| 01/06/2005 | WO2004089417A9 Drug-enclosing multilayer structure particulate and process for producing the same |
| 01/06/2005 | WO2004089396A3 Anti-fungal peptidomimetics |
| 01/06/2005 | WO2004076474A3 Polyethylene glycol modified interferon compositions and methods of use thereof |
| 01/06/2005 | WO2004075813A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep3 ii (prostaglandin e2 ep3 ii) |
| 01/06/2005 | WO2004074312A3 Tryptophyllin peptides and uses thereof |
| 01/06/2005 | WO2004073586A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor tg1019 (tg1019) |
| 01/06/2005 | WO2004071392A3 Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4) |
| 01/06/2005 | WO2004071378A3 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 01/06/2005 | WO2004062684A3 Treatment of thrombocytopenia with inhibitors of pacap |
| 01/06/2005 | WO2004060425A3 Compositions and methods of using collagen and mmpi |
| 01/06/2005 | WO2004051280A3 Identification of agonistic autoantibodies |
| 01/06/2005 | WO2004027026A3 Improved methods for preparing highly active april ligand polypeptides |
| 01/06/2005 | WO2003097688A9 Muteins of placental growth factor type 1, preparation method and application thereof |
| 01/06/2005 | WO2003050255A3 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 01/06/2005 | WO2003044040A9 Alpha-fetoprotein peptides and uses thereof |
| 01/06/2005 | WO2003032907A9 High-concentration protein formulations and method of manufacture |
| 01/06/2005 | WO2002096923A9 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
| 01/06/2005 | WO2002074234A3 Method and composition for treatment of skeletal dysplasias |
| 01/06/2005 | US20050005329 Isolated nucleotide sequence encoding polypeptide derived from algae Isochrysis galbana; expression of vector results in production of polyunsaturated fatty acid; use in pharmaceutical compositions, animal feeds and cosmetics |
| 01/06/2005 | US20050005328 Nucleotide sequence encoding a polypeptide derived from fungus Thraustochytrium aureum; expression of vector results in production of polyunsaturated fatty acid (omega 6-docosapentaenoic acid and docosahexaenoic acid); use in pharmaceutical compositions, animal feeds and cosmetics |
| 01/06/2005 | US20050005316 Extracellular matrix signaling molecules |
| 01/06/2005 | US20050004381 Therapy for headaches; analgesics; nausea; anxiolytic agents; anticonvulsants; central nervous system disorders |
| 01/06/2005 | US20050004352 Single-chain multiple antigen-binding molecule, its preparation and use |
| 01/06/2005 | US20050004351 Therapeutic and diagnostic domain 1 beta2GP1 polypeptides and methods of using same |
| 01/06/2005 | US20050004349 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 01/06/2005 | US20050004348 Sodium transport protein for use as tool in identifying modulator for treatment of hyperphosphatemia or hypophosphatemia |
| 01/06/2005 | US20050004230 Retroviral protease inhibitors |
| 01/06/2005 | US20050004222 Methods for prevention and treatment of gastrointestinal disorders |
| 01/06/2005 | US20050004119 Trypsin like serine protease enzyme inhibitors |
| 01/06/2005 | US20050004100 Cardiovascular disorders; kidney disorders; antiinflammatory agents |